-
12.06.2017 | Resistance to Antibiotics: The Good, the Bad, and the Ugly
Progress is being made to curb the misuse and overuse of antibiotics in humans and animals but much more needs to be done. Inter Press Service News Agency
-
11.25.2017 | Warning over ‘handful’ of scientists researching new antibiotics
PHARMAPHORUM | There are now less than 500 scientists studying antimicrobial resistance (AMR) worldwide and the UK government is losing focus on the public health crisis it could cause, experts have said at the launch of a new specialist research centre.
-
11.16.2017 | Antibiotic Resistance: EU SME alliance calls for specific support to thrive AMR R&D
European Biotechnology
-
10.27.2017 | Why is it so difficult to discover new antibiotics?
BBC News | Why, in this age of incredible medical and scientific endeavour and advance, is it so difficult to get the new antibiotics the world so desperately needs? How can we win the race against superbugs? Tim Jinks of Wellcome Trust examines the challenges the world faces in addressing drug-resistant bacteria.
-
09.26.2017 | Addressing Antimicrobial Resistance and Stewardship
JAMA
-
09.21.2017 | US panel advises on AMR reduction in humans, animals
CIDRAP | A panel of experts in human and veterinary medicine charged with advising the US government on antibiotic resistance has come up with a set of recommendations to boost development of vaccines, diagnostics, and new therapies that could reduce the spread of antimicrobial resistance (AMR) in humans and animals.
-
09.20.2017 | EU action needed to stop the world running out of antibiotics
SCIENCE BUSINESS | As WHO warns the antibiotics pipeline does not address the threat of bacterial resistance, the EU must step up and do more to galvanise R&D, accelerate innovation and help shape a coordinated global response to the impending crisis
-
09.19.2017 | WHO report paints dire picture of antibiotic development
CIDRAP |A new report today from the World Health Organization (WHO) argues that the antibiotics currently in clinical development are not sufficient to counter rising antimicrobial resistance (AMR), particularly in the pathogens that present the greatest threat to human health.
-
06.15.2017 | Bittere Pille (Bitter Pill)
The world is in urgent need of new antibiotics because bacteria are becoming resistant to existing drugs. This article (in German only) looks at the innovation gap that is posing a threat to global public health, and the solutions, including the CARB-X partnership, that have emerged to help develop new antibiotics to treat these drug-resistant bacteria. Der Spiegel Wissen
-
05.30.2017 | Stepping Up Global Health Towards Resilient, Responsible and Responsive Health Systems
G20 Health Initiative, Policy Paper 2017
Toggle navigation